SAWT BEIRUT INTERNATIONAL

| 17 June 2021, Thursday | النسخة العربية

Vietnam approves China’s Sinopharm vaccine for use against COVID-19

Vietnam health ministry has approved China’s Sinopharm vaccine for use against COVID-19, the official Vietnam News Agency reported on Friday, making it the third jab to be endorsed in the country that is tackling a new outbreak of infections.

Vietnam has previously approved the AstraZeneca vaccine and Russia’s Sputnik V.

Vietnam is trying to speed up its vaccine procurement drive to contain a more stubborn wave of infections, even though its overall case load and fatality numbers remain relatively low.

Minister of Health Nguyen Thanh Long said on Wednesday Vietnam was nearing its target of acquiring 150 million doses of vaccines this year to inoculate 75 percent of its 98 million population.

The country has taken delivery of nearly 2.9 million doses of coronavirus vaccine so far, mostly AstraZeneca shots and about one million have been administered.

Vietnam has recorded 49 deaths and just 8,115 cases overall, although nearly 60 percent of infections were in the past month.

The World Health Organization on Friday confirmed that a coronavirus mutation that Vietnamese authorities thought was a combination of the Indian and U.K. variants did not appear to be a new variant or hybrid.